The human brain NGF metabolic pathway is impaired in the pre-clinical and clinical continuum of Alzheimers disease

Clinical diagnosis of Alzheimer's disease

Guy M. McKhann, David A. Drachman, Marshall Folstein et al. · Neurology · 1984 · 28K citations · Full text

Medicine, Geriatric Medicine, Neurology +16

Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Reisa A. Sperling, Paul Aisen, Laurel Beckett et al. · Alzheimer s & Dementia · 2011 · 7.1K citations · Full text

Medicine, Neurology, Neuroscience +17

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

Suzanne S. Mirra, Albert Heyman, Daniel W. McKeel et al. · Neurology · 1991 · 5.1K citations

Medicine, Genetics, Neurology +17

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

Clifford R. Jack, David S. Knopman, William J. Jagust et al. · The Lancet Neurology · 2013 · 4.4K citations

Life Sciences, Neurology, Neuroscience +16

Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain

PJ Whitehouse, DL Price, R. G. Struble et al. · Science · 1982 · 3.6K citations

Life Sciences, Neurobiology, Neuroscience +17